Life Sciences Tools and Services
Company Overview of The EMMES Corporation
The EMMES Corporation operates as a contract research organization. Its products include EMMES AdvantageEDC, a platform that provides study design tools and data collection in electronic case report forms and data quality management; EMMES RTS, a platform to assist in coordination, collection, organization, and retrieval of regulatory documentation for investigational sites; and EMMES GlobalTrace, a materials/specimen management platform that tracks in real-time from collection at a clinical site to arrival and storage at a central laboratory or repository. The company’s services include statistical leadership and project management, study design and protocol development, Web-based data coll...
401 North Washington Street
Rockville, MD 20850
Founded in 1977
Key Executives for The EMMES Corporation
Chief Executive Officer and President
Chief Financial Officer and Vice President
Compensation as of Fiscal Year 2014.
The EMMES Corporation Key Developments
EMMES Corporation Wins $21.5 Million Federal Contract
Jun 22 14
EMMES Corp. won a federal contract valued at up to $21.5 million from the U.S. Department of Health and Human Services' National Institutes of Health, Bethesda, Maryland, for research and development services.
The EMMES Corporation Wins IDIQ Contract
Mar 18 14
The EMMES Corporation announced that it has been awarded an indefinite delivery, indefinite quantity (IDIQ) contract to become part of a clinical studies network established by the Biomedical Advanced Research and Development Authority (BARDA) to perform studies needed to develop medical countermeasures against agents of bioterrorism, pandemic influenza, and other public health threats. BARDA is part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. Under the contract, EMMES will provide a full range of services that support public health emergency preparedness. These include statistical expertise and project management, study design and protocol development, data collection, and data analysis and reporting. In addition, the company will also provide enhanced safety reporting through its pharmacovigilence program with both Emergency Medicine and Infectious Disease expertise and will manage a large team of subcontractors at laboratories and sites across the country. The two-year contract, which includes three one-year options, has a ceiling of $100 million. EMMES was one of five companies selected to compete for services under this IDIQ contract.
Clinical Research Management Inc., PPD Development (S) Pte Ltd., EMMES Corp, Rho Federal Systems Division, Inc. and Technical Resources International Inc. Win a $100 Million Federal Contract
Mar 13 14
Clinical Research Management Inc. won a share of a federal contract valued at up to $100 million from the U.S. Department of Health and Human Services' Office of the Secretary for research and development services on medical countermeasures clinical studies network. EMMES Corp, PPD Development L.P., Rho Federal Systems Division Inc., and Technical Resources International Inc. shared in the award amount.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|